Counter Analysis System News Today

Expression levels of several microRNAs in plasma samples can help predict the onset of pancreatic cancer up to 5 years prior to clinical diagnosis.

Adaptimmune Therapeutics (NASDAQ:ADAP – Get Free Report) and NanoString Technologies (NASDAQ:NSTG – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, dividends, analyst recommendations, valuation and risk. Valuation and Earnings This table compares Adaptimmune […]

StockNews.com began coverage on shares of NanoString Technologies (NASDAQ:NSTG – Get Free Report) in a research note issued on Monday. The brokerage set a “sell” rating on the biotechnology company’s stock. NanoString Technologies Stock Performance The firm has a market capitalization of $5.07 million, a price-to-earnings ratio of -0.03 and a beta of 1.24. The […]

Shares of NanoString Technologies, Inc. (NASDAQ:NSTG – Get Free Report) have been assigned a consensus recommendation of “Hold” from the six brokerages that are presently covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1 […]

Analysts at StockNews.com assumed coverage on shares of NanoString Technologies (NASDAQ:NSTG – Get Free Report) in a research report issued to clients and investors on Sunday. The brokerage set a “sell” rating on the biotechnology company’s stock. Separately, JPMorgan Chase & Co. lowered NanoString Technologies from an “overweight” rating to a “neutral” rating in a […]

StockNews.com initiated coverage on shares of NanoString Technologies (NASDAQ:NSTG – Free Report) in a report issued on Friday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Other equities analysts have also recently issued reports about the company. JPMorgan Chase & Co. downgraded NanoString Technologies from an overweight rating to a neutral […]

StockNews.com assumed coverage on shares of NanoString Technologies (NASDAQ:NSTG – Free Report) in a report issued on Wednesday morning. The firm issued a sell rating on the biotechnology company’s stock. A number of other equities analysts also recently commented on the company. Morgan Stanley decreased their target price on NanoString Technologies from $14.00 to $8.00 […]

Stock analysts at StockNews.com assumed coverage on shares of NanoString Technologies (NASDAQ:NSTG – Get Free Report) in a research report issued to clients and investors on Wednesday. The firm set a “sell” rating on the biotechnology company’s stock. NSTG has been the topic of several other research reports. JPMorgan Chase & Co. cut NanoString Technologies […]

StockNews.com began coverage on shares of NanoString Technologies (NASDAQ:NSTG – Free Report) in a research report report published on Tuesday. The brokerage issued a sell rating on the biotechnology company’s stock. A number of other brokerages have also recently commented on NSTG. Morgan Stanley cut their price target on shares of NanoString Technologies from $14.00 […]

Equities researchers at StockNews.com initiated coverage on shares of NanoString Technologies (NASDAQ:NSTG – Get Free Report) in a note issued to investors on Tuesday. The firm set a “sell” rating on the biotechnology company’s stock. NSTG has been the subject of several other research reports. TD Cowen reissued a “market perform” rating on shares of […]